← FDA Drug Approvals (Drugs@FDA)

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOUGERA PHARMS · Approved 2001-06-05

Drug application

FDA Application #

ANDA075502

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

Generic name

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

Active ingredients

BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

FOUGERA PHARMS

Manufacturer

E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC

First approval

2001-06-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown